glp-1 receptor agonists are contraindicated in and Diabetic Kidney Disease: A Call of Attention to Nephrologists Holding GLP-1 Agonists Prior to
Description
There is evidence from a large dataset of human clinical trials for fiber supplementation reducing constipation [93]
If patients feel unsure about their current dose, or find that it isnt working as expected, they should speak to a clinician
Chien C
December 2025 brought FDA approval for the oral version, designed for adults with obesity or overweight who also have at least one connected health issue
